ERICA BURG: Open Payments
NPI 1013925429 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$899 in 41 payments from 8 companies in 2025. Trend: 2023 $709 · 2024 $502 · 2025 $899
Food & beverage: $814Education: $85
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $375 |
| Janssen Biotech, Inc. | 10 | $179 |
| Celltrion USA Inc. | 13 | $165 |
| ABBVIE INC. | 3 | $58 |
| GENZYME CORPORATION | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Ipsen Biopharmaceuticals, Inc | 1 | $30 |
| Lilly USA, LLC | 1 | $15 |
Products named: VELSIPITY, TREMFYA, VEGZELMA, LINZESS, DUPIXENT, XIFAXAN, IQIRVO, OMVOH.
Industry payments across TX — which companies pay providers there.
